SCHEMBL26549026

SCHEMBL26549026

CC(C)Nc1nc(C2CC2)no1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
POLB P06746 2/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
IDH1 O75874 3/20 0.34
FABP4 P15090 5/20 0.33
FABP5 Q01469 5/20 0.33
OPRK1 P41145 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2961980 0.79 MTNR1A (0.43) PDE10AMTNR1AMTNR1BPOLBCASP3
SCHEMBL12299867 0.71 HCRTR1 (0.43) PDE10APOLBCASP3SENP7SENP6
SCHEMBL18997875 0.70 POLB (0.44) PDE10AMTNR1AMTNR1BPOLBCASP3
SCHEMBL11510529 0.70 TRPM8 (0.42) TRPM8
SCHEMBL13827635 0.69 POLB (0.40) MTNR1AMTNR1BPOLBCASP3SENP7
SCHEMBL21092169 0.69 IDH1 (0.43) PDE10AMTNR1AMTNR1BPOLBCASP3
SCHEMBL469197 0.69 POLB (0.40) MTNR1AMTNR1BPOLBCASP3SENP7
SCHEMBL23734140 0.68 TRPM8 (0.36) KDM4EALDH1A1TRPM8
SCHEMBL12259534 0.68 FABP4 (0.34) PDE10APOLBCASP3SENP7SENP6
SCHEMBL15479711 0.68 POLB (0.40) POLBCASP3SENP7SENP6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed